Published date: 
Thursday, 18 May, 2023

Although the data published by the University of Oxford and partners on the Phase 2 results of their trial in Burkina Faso did demonstrate high levels ofefficacy, the data on the R21 malaria vaccine cannot be reliably compared with Phase 3 trial results for RTS,S/AS01.

Birkett, A., Miller, Scott R., Soisson, Lorraine A. (2022. Nov. 21) The Importance of Exercising Caution When Comparing Results from Malaria Vaccines Administered in the EPI Schedule and on a Seasonal Schedule [Letter to the editor]. Am. J. Trop. Med. Hyg